Lysability of arterial thrombi assessed by magnetic resonance imaging

M Kozak1, U Mikac, A Blinc

  • 1Department of Vascular Diseases, University of Ljubljana Medical Centre, Ljubljana, Slovenia. matija.kozak@trnovo.kclj.si

Abstract

Insights

High MRI signal intensity in arterial thrombi may indicate resistance to thrombolytic therapy, potentially improving patient selection for treatments like streptokinase. This finding aids in predicting treatment success for occlusive arterial diseases.

Area of Science:

  • Vascular Medicine
  • Radiology
  • Interventional Cardiology

Background:

  • Intravascular thrombi evolve over time, altering their appearance on magnetic resonance imaging (MRI).
  • MRI may enhance patient selection for thrombolytic therapy.
  • This study investigated occlusive arterial thrombi in superficial femoral artery disease.

Purpose of the Study:

  • To analyze arterial thrombi using MRI.
  • To correlate MRI parameters with therapeutic outcomes.
  • To evaluate catheter-directed thrombolysis with streptokinase.

Main Methods:

  • Included 13 patients with subacute (2 weeks-3 months) and 4 with chronic (>6 months) arterial occlusions.
  • Measured MRI signal intensity on gradient echo images of thrombi.
  • Treated subacute thrombi with catheter-directed thrombolysis.

Main Results:

  • Thrombolysis was successful in 11 out of 13 patients.
  • Unsuccessfully treated thrombi showed significantly higher normalized MRI signal intensity (1.10 +/- 0.08) compared to successfully treated thrombi (0.72 +/- 0.17).
  • No significant difference in signal intensity was observed between subacute and chronic thrombi.

Conclusions:

  • High signal intensity on gradient echo MRI may predict resistance to thrombolytic therapy.
  • This finding could aid in optimizing treatment strategies for arterial occlusive diseases.